Parkinson's disease
Sunbird Bio Nabs $14M in Financing
The firm said that it will use the investments to support the development of its blood-based tests to aid the diagnosis and treatment of neurological disorders.
Neurology Dx Firm Amprion Closes $6M of Planned $15M Series B Round
The round, which was led by Formation Venture Engineering, will support commercialization of the company's SAAmplify-ɑSYN biomarker test as well as increased R&D.
The letter encourages drug developers to "further study and use" αSyn-SAA testing for selecting patients for clinical trials for Parkinson's and related diseases.
The company recently published a study in JAMA on the test and is in the middle of two additional clinical trials as it closes a $6 million Series A funding round.
Durin Technologies Closes $3.5M Funding Round
The company said it will use the funds to support commercialization of diagnostic tests for Alzheimer's and Parkinson's disease.